Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 14.30
-0.20 (-1.38%)
May 28, 2026, 4:14 PM GMT
Creo Medical Group Market Cap
Creo Medical Group has a market cap or net worth of 63.68 million as of May 28, 2026. Its market cap has increased by 54.35% in one year.
Market Cap
63.68M
Enterprise Value
55.38M
Revenue
6.00M
Ranking
n/a
PE Ratio
12.01
Stock Price
14.30
Market Cap Chart
Since December 9, 2016, Creo Medical Group's market cap has decreased from 64.46M to 63.68M, a decrease of -1.21%. That is a compound annual growth rate of -0.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 63.68M | 59.81% |
| Dec 31, 2025 | 39.84M | -49.19% |
| Dec 31, 2024 | 78.42M | -51.05% |
| Dec 29, 2023 | 160.20M | 255.34% |
| Dec 30, 2022 | 45.08M | -83.01% |
| Dec 31, 2021 | 265.37M | -13.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.84B |
| GSK plc | 76.45B |
| Haleon | 30.46B |
| Smith & Nephew | 9.72B |
| 4basebio | 75.07M |
| Venture Life Group | 68.83M |
| Shield Therapeutics | 67.84M |
| ECO Animal Health Group | 65.73M |